BACKGROUND: Data on colorectal cancer (CRC) in HIV-positive patients are limited. The study objective was to investigate and compare clinical presentation and outcome between HIV-positive and HIV-negative CRC patients. PATIENTS AND METHODS: Between September 1985 and November 2003 we identified 27 cases of HIV-positive CRC patients from the cancer registry database - Italian Cooperative Group AIDS and Tumours (GICAT); the clinical presentation/outcome information was retrieved. Each HIV-positive patient from our institution was randomly matched (ratio 1:2) with HIV-negative patients (54 controls) based on age, sex, and year of diagnosis in the same time period. Differences in clinical presentation, treatment, and overall survival were assessed. RESULTS: Of 1130 HIV-negative CRC patients, 54 were identified and matched with 27 HIV-positive patients. Compared with the HIV-negative patients, the HIV-positive patients had a higher risk of lower performance status (PS: > or =2) (odds ratio (OR) = 14.4; 95% confidence interval (CI): 3.6-57.7), a higher risk of unfavorable Dukes' stage (D) (OR = 4.9; 95% CI: 1.8-13.5), and a higher risk of poor grading (G3-G4) (OR = 5.0; 95% CI: 1.9-13.4). Median overall follow-up was 27 months (range: 2-212). At multivariate analysis, the only characteristics that significantly reduced the survival of the CRC patients were: HIV-positive status (hazard ratio (HR): 2.4; 95% CI: 1.1-5.2) and Dukes' stage D (HR: 3.7; 95% CI: 1.9-7.1). CONCLUSION: Our data show that HIV-positive CRC patients compared to HIV-negative patients have a poorer PS, an unfavorable Dukes' stage, higher grading and shorter survival. Copyright 2009 S. Karger AG, Basel.
BACKGROUND: Data on colorectal cancer (CRC) in HIV-positive patients are limited. The study objective was to investigate and compare clinical presentation and outcome between HIV-positive and HIV-negative CRC patients. PATIENTS AND METHODS: Between September 1985 and November 2003 we identified 27 cases of HIV-positive CRC patients from the cancer registry database - Italian Cooperative Group AIDS and Tumours (GICAT); the clinical presentation/outcome information was retrieved. Each HIV-positive patient from our institution was randomly matched (ratio 1:2) with HIV-negative patients (54 controls) based on age, sex, and year of diagnosis in the same time period. Differences in clinical presentation, treatment, and overall survival were assessed. RESULTS: Of 1130 HIV-negative CRC patients, 54 were identified and matched with 27 HIV-positive patients. Compared with the HIV-negative patients, the HIV-positive patients had a higher risk of lower performance status (PS: > or =2) (odds ratio (OR) = 14.4; 95% confidence interval (CI): 3.6-57.7), a higher risk of unfavorable Dukes' stage (D) (OR = 4.9; 95% CI: 1.8-13.5), and a higher risk of poor grading (G3-G4) (OR = 5.0; 95% CI: 1.9-13.4). Median overall follow-up was 27 months (range: 2-212). At multivariate analysis, the only characteristics that significantly reduced the survival of the CRC patients were: HIV-positive status (hazard ratio (HR): 2.4; 95% CI: 1.1-5.2) and Dukes' stage D (HR: 3.7; 95% CI: 1.9-7.1). CONCLUSION: Our data show that HIV-positive CRC patients compared to HIV-negative patients have a poorer PS, an unfavorable Dukes' stage, higher grading and shorter survival. Copyright 2009 S. Karger AG, Basel.
Authors: Manfred Hensel; Armin Goetzenich; Thomas Lutz; Albrecht Stoehr; Arend Moll; Jürgen Rockstroh; Nicola Hanhoff; Hans Jäger; Franz Mosthaf Journal: Dtsch Arztebl Int Date: 2011-02-25 Impact factor: 5.594
Authors: Avishek Kumar; Nihar Shah; Yashpal Modi; Hamid S Shaaban; Joseph DePasquale; Vincent A DeBari; Swaroopa Yerrabothala; Michael Maroules; Gunwant K Guron Journal: Med Oncol Date: 2011-06-28 Impact factor: 3.064
Authors: Greer A Burkholder; Ashutosh R Tamhane; Lauren E Appell; James H Willig; Michael S Saag; James L Raper; Andrew O Westfall; Michael J Mugavero Journal: AIDS Res Hum Retroviruses Date: 2015-01-06 Impact factor: 2.205
Authors: Fabrizio Di Benedetto; Giuseppe Tarantino; Giorgio Ercolani; Umberto Baccarani; Roberto Montalti; Nicola De Ruvo; Massimiliano Berretta; Gian Luigi Adani; Matteo Zanello; Marcello Tavio; Nicola Cautero; Umberto Tirelli; Antonio D Pinna; Giorgio E Gerunda; Giovanni Guaraldi Journal: Oncologist Date: 2013-05-10
Authors: Sara C Keller; Florence Momplaisir; Vincent Lo Re; Craig Newcomb; Qing Liu; Sarah J Ratcliffe; Judith A Long Journal: AIDS Care Date: 2013-11-05
Authors: Meredith S Shiels; Glenn Copeland; Marc T Goodman; Janna Harrell; Charles F Lynch; Karen Pawlish; Ruth M Pfeiffer; Eric A Engels Journal: Cancer Date: 2015-03-04 Impact factor: 6.921